Robert R. Ruffolo, Jr.
Board Member
Elicio Therapeutics, Inc. (ELTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert R. Ruffolo, Jr.
Robert R. Ruffolo, Jr. is recorded as Board Member at Elicio Therapeutics, Inc. (ELTX). Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Robert R. Ruffolo, Jr. was appointed Class II Director, effective June 1, 2023.
“Robert R. Ruffolo, Jr., PhD, FCPP, Assaf Segal and Karen J. Wilson being appointed as Class II directors of the Company whose terms expire at the Company's 2025 annual meeting of stockholders”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.